- Home
- About Us
- Industry
- Services
- Reading
- Contact Us
Emphasis on Type (Wearable, Mobile-Based Applications, Sensors, and Others); Therapeutic Area (Cardiovascular and Metabolic Disorders (CVMD), Respiratory Disorders, Psychiatric Disorders, Sleep & Movement Disease, Neurological Disorders, Musculoskeletal Disorders, and Others); End-Use (Healthcare Companies, Healthcare Providers, Payers, and Others); and Region/Country
The Digital Biomarkers market held 3 billion in 2022 and is expected to grow at a strong CAGR of around 22% during the forecast period (2023-2030). Digital biomarkers are measurable biological signals or data that can be collected using digital technologies, such as wearable devices and mobile health apps. They can be used to diagnose, monitor, and treat various health conditions, including chronic diseases such as diabetes and heart disease. The digital biomarkers market is a rapidly growing industry that involves the use of digital technologies to measure and analyze biological signals and data. Digital biomarkers are used to diagnose, monitor, and treat various health conditions, including chronic diseases such as diabetes and heart disease.
Some of the major players operating in the market are ActiGraph, LLC; AliveCor, Inc.; Koneksa Health.; ALTOIDA; Amgen Inc; Biogen; VivoSense; IXICO plc; adherium.; and Neurotrack Technologies, Inc. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst type, the mobile-based applications segment is expected to grow at the highest CAGR during the forecast period.”
Based on type, the market is segmented into wearable, mobile-based applications, sensors, and others. As per our analysis, the mobile-based applications segment is expected to grow at the highest CAGR during the forecast period. The mobile-based applications segment is expected to grow at a significant rate in the coming years, as the use of mobile devices continues to increase, and more healthcare providers adopt digital technologies. The growing availability of mobile devices and the increasing awareness of the importance of self-monitoring and preventative healthcare are also driving the growth of this segment.
“Amongst therapeutic area, the respiratory disorders segment held the dominant share in 2022.”
Based on the therapeutic area, the market is segmented into cardiovascular and metabolic disorders (CVMD), respiratory disorders, psychiatric disorders, sleep & movement disease, neurological disorders, musculoskeletal disorders, and others. As per our analysis, the respiratory disorders segment held the dominant share in 2022. The increasing prevalence of respiratory disorders, along with the rising level of air pollution, is attributed to the growth of the segment. For instance, as per the Asthma and Allergy Foundation of America, In 2019, asthma accounted for 4.9 million doctors’ office visits.
Amongst end-user, the mobile-based applications segment is expected to grow at the highest CAGR during the forecast period.”
Based on end-use, the market is segmented into healthcare companies, healthcare providers, payers, and others. As per our analysis, the payers segment is expected to grow at the highest CAGR during the forecast period. The payers segment is a key component of the digital biomarkers market, as digital biomarkers have the potential to improve the efficiency and effectiveness of healthcare delivery. Payers, such as insurance companies and government agencies, are responsible for funding healthcare services and are interested in using digital biomarkers to reduce healthcare costs and improve patient outcomes. These are the responsible factors for the growth of the segment.
“Asia Pacific is expected to grow with the highest CAGR Digital Biomarkers market during the forecast period.”
The Asia Pacific region is a key player in the digital biomarkers market, as the use of digital biomarkers is becoming increasingly popular in this region. The increasing awareness of the importance of self-monitoring and preventative healthcare, as well as the growing availability of mobile devices and the increasing prevalence of chronic diseases, are driving the growth of the digital biomarkers market in this region.
Digital Biomarkers Market Report Coverage
Reasons to buy this report:
Customization Options:
The global digital biomarkers market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
Research Methodology for the Digital Biomarkers Market Analysis (2023-2030)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global digital biomarkers market were the three major steps undertaken to create and analyze the adoption of digital biomarkers in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of global digital biomarkers market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the digital biomarkers market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the Digital Biomarkers market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as type, therapeutic area, and end-use. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the Digital Biomarkers market. Further, we conducted factor analysis using dependent and independent variables such as type, therapeutic area, and end-use of the digital biomarkers market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the Digital Biomarkers market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global Digital Biomarkers market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2030 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global Digital Biomarkers market. data was split into several segments & sub-segments post studying various parameters and trends in the areas of the type, therapeutic area, and end-use in the global digital biomarkers market.
The main objective of the Global Digital Biomarkers Market Study
The current & future market trends of the global digital biomarkers market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
Customers who bought this item also bought